(Harakani Devlet Hastanesi, Endokrinoloji ve Metabolizma Kliniği, Kars, Türkiye)
(Muradiye Devlet Hastanesi, Genel Cerrahi Kliniği, Bursa, Türkiye)
(Uludağ Üniversitesi, Tıp Fakültesi, Endokrinoloji ve Metabolizma Anabilim Dalı, Bursa, Türkiye)
Yıl: 2018Cilt: 34Sayı: 3ISSN: 2651-3137 / 2651-3153Sayfa Aralığı: 167 - 174İngilizce

92 0
Bariatric Surgery: Outcomes and Follow-Up
Nowadays, obesity is a very important public health problem due to its related comorbidities. Major treatment modalities include lifestyle modifiation, diet, and medical and surgical treatments. Bariatric surgery is the most successful treatment modality in obesity treatment. Owing to its ability to achieve weight loss and improve comorbidities accompanying obesity, it is now focused on metabolic control rather than weight loss. When choosing an operation method, the purpose of the surgery (weight loss and/or metabolic control) should be decided by taking into account the experience of the surgeon and the center, patient preference, and individual risk assessment results. In the past two decades, complication rates have gradually decreased because of the development of minimally invasive methods, increased experience, and adoption of a multidisciplinary approach in bariatric surgery. However, there are still complications requiring reoperation and hospitalization. Patients should be informed about the operation and postoperative diet and follow-up, realistic weight loss goals should be targeted, and operation and postoperative patient follow-up should be performed in experienced centers.
DergiDerlemeErişime Açık
  • 1. Capehorn MS, Haslam DW, Welbourn R. Obesity Treatment in the UK Health System. Curr Obes Rep 2016; 5: 320-6. [CrossRef]
  • 2. Jammah AA. Endocrine and metabolic complications after bariatric surgery. Saudi J Gastroenterol 2015; 21: 269-77. [CrossRef]
  • 3. Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) 2008; 32: 1431-7. [CrossRef]
  • 4. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults. J Am Coll Cardiol 2014; 63: 2985- 3023. [CrossRef]
  • 5. Obesity: preventing and managing the global epidemic. Report of a WHO colsultation. World Health Organ Tech Rep Ser 2000; 894: i-xii,1-253.
  • 6. Pories WJ, Dohm LG, Mansfield CJ. Beyond the BMI: the search for better guidelines for bariatric surgery. Obesity 2010; 18: 865-71. [CrossRef]
  • 7. Mechanick JI, Youdim A, Jones DB, Garvey WT, Hurley DL, McMahon MM, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring) 2013; 21(Suppl 1): S1-27. [CrossRef]
  • 8. Caravatto PP, Petry T, Cohen R. Changing guidelines for metabolic surgery: Now it’s the time! Curr Atheroscler Rep 2016; 18: 47. [CrossRef]
  • 9. American Diabetes Assosiation. Obesity management for the treatment of type 2 diabetes. Diabetes Care 2017; 40(Suppl 1): S57- 63. [CrossRef]
  • 10. Giordano S, Victorzon M. Bariatric surgery in elderly patients: a systematic review. Clin Interv Aging 2015; 10: 1627-35.
  • 11. Lim RB. Bariatric operations for management of obesity: Indications and preoperative preparation. Available from: https. source=search_ result&search=Bariatric%20 operations%20 for%20 management%20 of%20 obesity:%20 Indications%20 and%20 preoperative%20 preparation.&selectedTitle=1~150
  • 12. Thorell A, MacCormick AD, Awad S, Reynolds N, Roulin D, Demartines N, et al. Guidelines for perioperative care in bariatric surgery: Enhanced Recovery After Surgery (ERAS) Society recommendations. World J Surg 2016; 40: 2065-83. [CrossRef]
  • 13. Kozlowski T, Kozakiewicz K, Dadan J, Mysliwiec P. Innovative solutions in bariatric surgery. Gland Surg 2016; 5: 529-36. [CrossRef]
  • 14. Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg 2013; 23: 427-36. [CrossRef]
  • 15. Keating C, Neovius M, Sjoholm K, Peltonen M, Narbro K, Eriksson JK, et al. Health-care costs over 15 years after bariatric surgry for patients with different baseline glucose status: results from the Sweedish Obese Subjects study. Lancet Diabetes Endocrinol 2015; 3: 855-65. [CrossRef]
  • 16. Birkmeyer NJ, Dimick JB, Share D, Hawasli A, English WJ, Genaw J, et al. Michigan Bariatric Surgery Collaborative. Hospital complication rates with bariatric surgery in Michigan. JAMA 2010;304: 435-442. [CrossRef]
  • 17. Yumuk V, Tsigos C, Fried M, Schindler K, Busetto L, Micic D, et al. European guidelines for obesity management in adults. Obes Facts 2015; 8: 402-24. [CrossRef]
  • 18. Marsk R, Jonas E, Rasmussen F, Näslund E. Nationwide cohort study of post-gastric bypass hypoglisemia including 5040 patients undergoing surgery for obesity in 1986-2006 in Sweeden. Diabetologia 2010; 53: 2307-11. [CrossRef]
  • 19. McBridge CL, Petersen A, Sudan D, Thompson J. Short bowel syndrome following bariatric surgical procedures. Am J Surg 2006; 16: 488-95.
  • 20. Tack J, Arts J, Caenepeel P, De Wulf D, Bisschops R. Pathhophysiology, diagnosisand management of postoperative dumping syndrome. Nat Rev Gastroenterol Hepatol 2009; 6: 583- 90. [CrossRef]
  • 21. Hamad G. Bariatric surgery: Postoperative and long-term management of the uncomplicated patient. Available from: https.www. tive-and-long-term-management-of-the-uncomplicated-patient?- source=search_ result&search=Postoperative%20 and%20 longterm%20 management%20 of%20 the%20 uncomplicated%20 patient.&selectedTitle=1~150
  • 22. Mechanick JI, Kushner RF, Sugerman HJ, Gonzalez-Campoy JM, Collazo-Clavell ML, Guven S, et al. American Association of Cinical Endocrinologists. The Obesity Society, and American Society for Metabolic & Bariatric Surgery Medical guidelines for clinical practice fort he periperative nutritional, metabolic and nonsurgical support of the bariatric surgery patint. Endocr Pract 2008; 14(Suppl 1): 1-83. [CrossRef]
  • 23. Kushner RF, Cummings S, Herron DM. Bariatric surgery: Postoperative nutritional management. contents/bariatric-surgery-postoperative-nutritional-management?source=search_result&search=Bariatric%20 surgery:%20 Postoperative%20 nutritional%20 management.&selectedTitle=1~150
  • 24. Ito MK, Gonçalves VSS, Faria SLCM, Moizé V, Porporatti AL, Guerra ENS, et al. Effect of protein intake on the protein status and lean mass of post-bariatric surgery patients: a systematic review. Obes Surg 2017; 27: 502-12. [CrossRef]
  • 25. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-37. [CrossRef]
  • 26. Telem D, Greenstein AJ, Wolfe B. Medical outcomes following bariatric surgery. result&search=- medical%20 outcomes%20 following%20 bariatric%20 surgery&selected Title=1~150.
  • 27. Gloy VL, Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone G, et al. Bariatric surgery versus non-surgical treatment for obesity: Asystematic review and meta-analysis of randomised controlled trials. BMJ 2013; 347: f5934. [CrossRef]
  • 28. Christou NV, Sampalis JS, Liberman M, Look D, Auger S, McLean AP, et al. Surgery decreases long-term mortality, morbidity and health care use in morbidly obese patients. Ann Surg 2004; 240: 416-24. [CrossRef]
  • 29. Hutter MM, Schirmer BD, Jones DB, Ko CY, Cohen ME, Merkow RP, et al. First report from the American Collage of Surgeons Bariatric Surgery Center Network: laparoskopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass. Ann Surg 2011; 254: 410-22. [CrossRef]
  • 30. Schauer PR, Bhatt DL, Kirvan JP, Wolski K, Brethauer SA, Navaneethan SD, et al. STAMPEDE Investigators. Bariatric surgery versus intensive medical therapy for diabetes- 3 year outcomes. N Eng J Med 2014; 370: 2002-13. [CrossRef]
  • 31. Kashyap SR, Bhatt DL, Schauer PR, STAMPEDE Investigators. bariatric surgery vs. advanced practice medical management in the treatment of type 2 diabetes mellitus: rationale and design of the Surgical Therapy And Medications Potentially Eradicate Diabetes Efficiently trial (STAMPEDE). Diabetes Obes Metab 2010; 12: 452-4. [CrossRef]
  • 32. Gholam PM, Kotler DP, Flancbaum LJ. Liver pathology in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery. Obes Surg 2002; 12: 49-51. [CrossRef]
  • 33. Clark JM, Diehl AM. Nonalcoholic fatty liver disease an under recognized cause of cryptogenic cirrhosis. JAMA 2003; 289: 3000-4. [CrossRef]
  • 34. Heber D, Greenway FL, Kaplan LM, Livingston E, Salvador J, Still C, et al. Endocrine and nutritional management of the post-bariatric surgery patient: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2010; 95: 4823-43. [CrossRef]
  • 35. Pugnale N, Giusti V, Suter M, Zysset E, Héraïef E, Gaillard RC, et al. Bone metabolism and risk of secondary hyperparathyroidism 12 months after gastric banding in obese pre-menopausal women. Int J Obes Relat Metab Disord 2003; 27: 110-6. [CrossRef]
  • 36. Nevitt MC. Obesity outcomes in disease management: clinical outcomes for ostroarthritis. Obes Res 2002; 10(Suppl 1): S33-7. [CrossRef]
  • 37. Musella M, Milone M, Bellini M, Sosa Fernandez LM, Leongito M, Milone F. Effect of bariatric surgery on obesity releated infertility. Surg Obes Relat Dis 2012; 8: 445-9. [CrossRef]
  • 38. Kushner RF, Sorensen KW. Prevention of weight regain following bariatric surgery. Curr Obes Rep 2015; 4: 198-206. [CrossRef]
  • 39. Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al. Lyfesytle, diabetes and cardiovascular risk factors 10 years after bariatric surgery. N Eng J Med 2004; 351: 2683-93. [CrossRef]
  • 40. Colles SL, Dixon JB, O’Brien PE. Grazing and loss of control related to eating: two high risk factors following bariatric surgery. Obesity 2008; 16: 615-6. [CrossRef]

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.